Ðǿմ«Ã½

    Advertisement
    Women's Health12:58Mounjaro Obesity Ozempic
    Medical Daily10:37Mounjaro Obesity Ozempic
    The Mirror04:47Hair Loss Health Global Health
    Medical Daily12:50Hair Loss Health Global Health
    Asia Today00:27Obesity Biotechnology Pharma
    Korea JoongAng Daily23:24Obesity Biotechnology Pharma
    Medical Daily13:08The Lancet Health Global Health
    News-Medical.Net23:42The Lancet Health Global Health
    Pharmaceutical Technology06:39Obesity WHO
    News-Medical.Net10:57Obesity WHO
    Proactive Investors (US)02:38Novo Nordisk Mounjaro Pharma
    Medical Daily21:25Novo Nordisk Mounjaro Pharma
    pharmaphorum06:43Obesity Ozempic Pharma
    The Financial Express12:25Eli Lilly Obesity Mounjaro
    Medpage Today17:35Mounjaro Health Global Health
    Medpage Today15:53Mounjaro Health Global Health
    LADbible08:04Ozempic
    In the last hour
    Korea JoongAng Daily02:53
    Yesterday
    Medical Daily19:31 8-Oct-26
    Newswise (Press Release)14:22 8-Oct-26
    Women's Health12:58 8-Oct-26
    The Financial Express12:25 8-Oct-26
    The Diabetes Times06:47 8-Oct-26
    Pharmaceutical Technology06:39 8-Oct-26
    International Tennis Integrity Agency (Press Release)03:58 8-Oct-26
    Asia Today00:27 8-Oct-26
    In the last 7 days
    Korea JoongAng Daily23:24 7-Oct-26
    PR Newswire (Press Release)09:04 7-Oct-26
    PR Newswire (Press Release)08:34 7-Oct-26
    LADbible08:04 7-Oct-26
    TIME08:03 7-Oct-26
    Toronto Star05:22 7-Oct-26
    Kiplinger.com05:21 7-Oct-26
    JD Supra10:17 6-Oct-26
    PR Newswire (Press Release)09:29 6-Oct-26
    Daily Record08:07 6-Oct-26
    PR Newswire (Press Release)07:06 6-Oct-26
    Pharmaceutical Technology06:35 6-Oct-26
    Asahi Shimbun03:56 6-Oct-26
    Medpage Today16:39 5-Oct-26
    AIChE14:00 5-Oct-26
    Medical Daily12:50 5-Oct-26
    Medical Daily10:37 5-Oct-26
    Wellbeing News09:33 5-Oct-26
    RTT News09:20 5-Oct-26
    PR Newswire (Press Release)07:51 5-Oct-26
    Manchester Evening News05:42 5-Oct-26
    Plymouth Live05:14 5-Oct-26
    My London05:05 5-Oct-26
    The Mirror04:47 5-Oct-26
    The Motley Fool09:21 4-Oct-26
    The Motley Fool05:17 4-Oct-26
    The Mirror03:14 4-Oct-26
    Medical Daily13:08 3-Oct-26
    Medpage Today17:01 2-Oct-26
    Allure15:38 2-Oct-26
    Gizmodo15:29 2-Oct-26
    Medical Daily14:56 2-Oct-26
    Medical Daily14:56 2-Oct-26
    Medical Daily14:56 2-Oct-26
    News-Medical.Net10:57 2-Oct-26
    Medical Bag10:34 2-Oct-26
    pharmaphorum06:43 2-Oct-26
    Pulse06:25 2-Oct-26
    Clinical Trials Arena06:19 2-Oct-26
    PR Newswire (Press Release)05:03 2-Oct-26
    Knowridge Science Report04:58 2-Oct-26
    ThisDay Live02:44 2-Oct-26
    Proactive Investors (US)02:38 2-Oct-26
    Korea Biomedical Review01:08 2-Oct-26
    Korea Biomedical Review01:01 2-Oct-26
    In the last month
    Medical Daily23:50 1-Oct-26
    MailOnline19:13 1-Oct-26
    Science Media Centre18:15 1-Oct-26
    Medpage Today17:35 1-Oct-26
    Medpage Today15:53 1-Oct-26
    The Times of India15:40 1-Oct-26
    Medical Daily14:11 1-Oct-26
    The Observer13:14 1-Oct-26
    Council on Foreign Relations12:52 1-Oct-26
    NewsMax12:36 1-Oct-26
    Medical Daily11:28 1-Oct-26
    Clinical Trials Arena08:54 1-Oct-26
    Knowridge Science Report07:25 1-Oct-26
    PR Newswire (Press Release)07:04 1-Oct-26
    Proactive Investors (UK)06:16 1-Oct-26
    The Observer06:05 1-Oct-26
    TIME06:01 1-Oct-26
    pharmaphorum05:16 1-Oct-26
    pharmaphorum05:06 1-Oct-26
    Pharmaceutical Technology04:40 1-Oct-26
    The Independent04:32 1-Oct-26
    News-Medical.Net23:42 30-Sep-26
    Medical Daily21:25 30-Sep-26
    Korea Biomedical Review21:01 30-Sep-26
    PR Newswire (Press Release)18:06 30-Sep-26
    ABC Online14:59 30-Sep-26
    RTT News13:48 30-Sep-26
    Pharmaceutical Technology13:15 30-Sep-26
    The Motley Fool12:26 30-Sep-26
    Benzinga11:29 30-Sep-26
    The Diabetes Times10:51 30-Sep-26
    Psychiatry Advisor10:51 30-Sep-26
    The Motley Fool10:34 30-Sep-26
    Manufacturing Chemist10:29 30-Sep-26
    Benzinga10:29 30-Sep-26
    New Scientist10:20 30-Sep-26
    PR Newswire (Press Release)10:17 30-Sep-26
    Novo Nordisk08:48 30-Sep-26
    pharmaphorum07:14 30-Sep-26
    PR Newswire (Press Release)05:48 30-Sep-26
    PR Newswire (Press Release)02:00 30-Sep-26
    Korea Biomedical Review01:15 30-Sep-26
    Korea Biomedical Review01:00 30-Sep-26
    News-Medical.Net23:17 29-Sep-26
    The Motley Fool21:20 29-Sep-26
    Knowridge Science Report19:35 29-Sep-26
    Knowridge Science Report19:35 29-Sep-26
    Scientific American19:30 29-Sep-26
    PR Newswire (Press Release)18:03 29-Sep-26
    TIME18:02 29-Sep-26
    Medpage Today14:49 29-Sep-26
    Pharmaceutical Technology14:11 29-Sep-26
    Medical Daily13:10 29-Sep-26
    RTT News11:52 29-Sep-26
    London Review of Books10:09 29-Sep-26
    Study Finds09:20 29-Sep-26
    pharmaphorum09:12 29-Sep-26
    RTT News07:17 29-Sep-26
    PR Newswire (Press Release)07:02 29-Sep-26
    Novo Nordisk06:07 29-Sep-26
    PR Newswire (Press Release)03:01 29-Sep-26
    view more headlines
    9 Oct 02:53

    About our Tirzepatide news

    Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.